$82.44 +0.54 (0.66%) Incyte Corp - NASDAQ

Aug. 24, 2016 | 04:00 PM
Last Trade: 82.44
Trade Time: Aug 24 04:00 PM Eastern Daylight Time
Change: +0.54 (0.66%)
Prev Close: 81.90
Open: 81.55
Bid: 82.43
Ask: 82.48
  1. No results found.
  1. Mid-Day Market Update: Dow Drops Over 300 Points; Cisco Shares Surge Following Strong Q2 Results

    Benzinga | Feb. 11, 2016 | 12:38PM EST
  2. Incyte Plummets After Stopping Trial Of Jakafi In Pancreatic Cancer

    IBD | Feb. 11, 2016 | 11:16AM EST
  3. Mid-Morning Market Update: Markets Open Lower; PepsiCo Posts In-Line Q4 Profit

    Benzinga | Feb. 11, 2016 | 09:48AM EST
  4. CTI-Baxalta Drug Withdrawn, Removing Potential Incyte Rival

    IBD | Feb. 10, 2016 | 13:50PM EST
  5. Mid-Afternoon Market Update: Dow Rises Over 100 Points; eBay Shares Drop On Disappointing Outlook

    Benzinga | Jan. 28, 2016 | 14:31PM EST
  6. Mid-Day Market Update: Facebook Surges On Strong Results; ServiceNow Shares Slip

    Benzinga | Jan. 28, 2016 | 12:00PM EST
  7. Mid-Morning Market Update: Markets Open Higher; Ford Tops Q4 Views

    Benzinga | Jan. 28, 2016 | 10:06AM EST
  8. Last-Hour Rally Erases Midday Losses As Indexes Close Mixed

    IBD | Jan. 19, 2016 | 16:49PM EST
  9. Benzinga's Top Initiations

    Benzinga | Jan. 5, 2016 | 09:54AM EST
  10. The 5 Top-Performing Big-Cap Drug Stocks Of 2015

    IBD | Dec. 30, 2015 | 14:16PM EST
  11. Incyte Announces Two Phase 3 Studies Show Sustained Benefits of Jakafi in Patients with Myeloproliferative Neoplasms (MPNs)

    Benzinga | Dec. 5, 2015 | 10:22AM EST
  12. Incyte Announces Phase 3 RESPONSE-2 Study of Jakafi Meets Primary Endpoint

    Benzinga | Dec. 5, 2015 | 10:20AM EST
  13. 3 Big Pharma Upgrades (And One Downgrade) At Barclays

    IBD | Dec. 1, 2015 | 15:31PM EST
  14. Goldman Sachs' Top 4 Smid-Cap Biotech Picks

    IBD | Nov. 18, 2015 | 15:36PM EST
  15. Lilly, Incyte Announce Data Demonstrate Baricitinib Superiority to Adalimumab in Improving Signs and Symptoms of RA

    Benzinga | Nov. 7, 2015 | 20:04PM EST
Trading Center